Panayiotidis Panayiotis
Panayiotidis Panayiotis
Verified email at
Cited by
Cited by
Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic …
AN Akbar, NJ Borthwick, RG Wickremasinghe, P Panayiotidis, D Pilling, ...
European journal of immunology 26 (2), 294-299, 1996
Thalidomide and dexamethasone combination for refractory multiple myeloma
MA Dimopoulos, K Zervas, G Kouvatseas, E Galani, V Grigoraki, ...
Annals of Oncology 12 (7), 991-995, 2001
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic …
A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, ...
The Lancet Oncology 17 (2), 200-211, 2016
Waldenstrom’s macroglobulinemia: clinical features, complications, and management
MA Dimopoulos, P Panayiotidis, LA Moulopoulos, P Sfikakis, M Dalakas
Journal of Clinical Oncology 18 (1), 214-214, 2000
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
P Panayiotidis, D Jones, K Ganeshaguru, L Foroni, AV Hoffbrand
British journal of haematology 92 (1), 97-103, 1996
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label …
P Hillmen, T Robak, A Janssens, KG Babu, J Kloczko, S Grosicki, ...
The Lancet 385 (9980), 1873-1883, 2015
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ...
The Lancet Oncology 19 (6), 747-757, 2018
Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma
M Dreyling, A Santoro, L Mollica, S Leppä, GA Follows, G Lenz, WS Kim, ...
Journal of Clinical Oncology 35 (35), 3898-3905, 2017
Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitro
P Panayiotidis, K Ganeshaguru, SAB Jabbar, AV Hoffbrand
British journal of haematology 85 (3), 439-445, 1993
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ...
British journal of haematology 137 (3), 240-243, 2007
B-cell kinase lyn deficiency in patients with systemic lupus erythematosus
SNC Liossis, EE Solomou, MA Dimopoulos, P Panayiotidis, ...
Journal of Investigative Medicine 49 (2), 157-165, 2001
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study
K Zervas, MA Dimopoulos, E Hatzicharissi, A Anagnostopoulos, ...
Annals of oncology 15 (1), 134-138, 2004
Treatment of Waldenstrom’s macroglobulinemia with thalidomide
MA Dimopoulos, A Zomas, NA Viniou, V Grigoraki, E Galani, C Matsouka, ...
Journal of clinical oncology 19 (16), 3596-3601, 2001
Iron chelators induce apoptosis in proliferating cells
D Hileti, P Panayiotidis, AV Hoffbrand
British journal of haematology 89 (1), 181-187, 1995
Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
P Panayiotidis, K Ganeshaguru, L Foroni, AV Hoffbrand
Leukemia 9 (7), 1227-1232, 1995
Ofatumumab+ chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukemia (CLL): results of the phase III study complement 1 (OMB110911)
P Hillmen, T Robak, A Janssens, K Govindbabu, S Grosicki, J Mayer, ...
Blood, The Journal of the American Society of Hematology 122 (21), 528-528, 2013
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
P Blombery, ER Thompson, K Jones, GM Arnau, S Lade, JF Markham, ...
Haematologica 101 (9), e387, 2016
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
V Ljungström, D Cortese, E Young, T Pandzic, L Mansouri, K Plevova, ...
Blood, The Journal of the American Society of Hematology 127 (8), 1007-1016, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care
TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ...
The oncologist 17 (2), 239, 2012
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
AH Wei, P Montesinos, V Ivanov, CD DiNardo, J Novak, K Laribi, I Kim, ...
Blood, The Journal of the American Society of Hematology 135 (24), 2137-2145, 2020
The system can't perform the operation now. Try again later.
Articles 1–20